Serum-Derived Exosomal Proteins As Potential Candidate Biomarkers for Hepatocellular Carcinoma
Liping Zhao,Jiahui Shi,Lei Chang,Yihao Wang,Shu Liu,Yuan Li,Tao Zhang,Tao Zuo,Bin Fu,Guibin Wang,Yuanyuan Ruan,Yali Zhang,Ping Xu
DOI: https://doi.org/10.1021/acsomega.0c05408
IF: 4.1
2021-01-01
ACS Omega
Abstract:Hepatocellular carcinoma (HCC) is the most common form of hepatic malignancies. The diagnosis of HCC remains challenging due to the low sensitivity and specificity of the diagnostic method. Exosomes, which are abundant in various proteins from parent cells, play pivotal roles in intercellular communication and have been confirmed as promising sources of disease biomarkers. Herein, we performed a simple but robust proteomic profiling on exosomes derived from 1 μL of serum using a data-independent acquisition (DIA) method for the first time, to screen potential biomarkers for the diagnosis of HCC. Ten pivotal differentially expressed proteins (DEPs) (von Willebrand factor (VWF), LGALS3BP, TGFB1, SERPINC1, HPX, HP, HBA1, FGA, FGG, and FGB) were screened as a potential candidate biomarker panel, which could completely discriminate patients with HCC from normal control (NC). Interestingly, Gene Expression Profiling Interactive Analysis (GEPIA) revealed that the expression levels of four genes increased and those of six genes decreased in HCC tissues compared with normal tissues, which were in concordance with protein expression levels. In conclusion, we screened 10 exosomal proteins holding promise for acting as a potential candidate biomarker panel for detection of HCC through a simple but robust proteomic profiling.